Availability: In Stock

Individualized Diabetes Management

A Guide for Primary Care

ISBN: 9781498762090
ISBN: 9781498762090

Ημ. Έκδοσης







Κύριος Συγγραφέας

35,00(Περιλαμβάνεται ΦΠΑ 6%)

A Guide for Primary Care

Διαθεσιμότητα: 23-28 ημέρες



•Provides guidance to the primary care multi-professional team

•Covers all the most recent developments in the pharmacological field

• Focuses on an individualised approach to care


In the past few decades a revolution in our approach to treating type 2 diabetes has occurred following the recognition that the condition is caused by multiple defects. A range of new treatments are now available, with many more forthcoming, utilising differing mechanisms of action that allow targeted and more effective therapy of this multifactorial disease than ever before.

The increasing requirement in the UK to move much of diabetes practice into the community requires much more detailed knowledge of the condition by GPs and practice nurses. In this bespoke book, the authors aim to show how new mechanisms of glucose control and advances in treatments arising from this can tailor treatment to the individual in primary care. This book incorporates the recently published ADA/EASD guidelines and the 2015 update from the National Institute for Health and Clinical Excellence (NICE).

Essential reading for the multi-professional diabetes care team, this book should also be of interest to hospital specialists in training.


1. Introduction 2. Overview of type 2 diabetes, epidemiology,
complications and costs 3. Challenges to glycaemic control (“Deadly
Triad” of progressive disease, clinical inertia and poor adherence to
management plans), how these can be overcome and how these all interlink
4. Individualised management including individualised lifestyle plans
and pharmacotherapy (as emphasised in ADA/EASD Guidelines) 5. Barriers
to adherence (poor tolerability- particularly weight gain and
hypoglycaemia) and how modern therapies may overcome some of these
problems 6. Advantages and disadvantages of new therapies – discussing
each in turn, and in context of drug combinations that will be
acceptable to patients and help overcome clinical inertia and poor
adherence 7. Importance of multi-professional care, education,
development of individualised management plans etc.